Global BCG Vaccine for Tuberculosis (TB) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 - Market Study Report

Global BCG Vaccine for Tuberculosis (TB) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Format: PDF   |   Report ID: 5513630   |   Published Date: August 2022   |   Pages:  114  

Choose License
The BCG Vaccine for Tuberculosis (TB) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global BCG Vaccine for Tuberculosis (TB) market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospitals accounting for % of the BCG Vaccine for Tuberculosis (TB) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Type segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, and AJ Vaccines, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
BCG Vaccine for Tuberculosis (TB) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

    Immune Type
    Therapy Type

Market segment by Application can be divided into

    Hospitals
    Clinics
    Others

The key market players for global BCG Vaccine for Tuberculosis (TB) market are listed below:

    Merck
    Sanofi Pasteur
    Japan BCG Lab
    China National Biotec
    AJ Vaccines
    Serum Institute of India
    Intervax
    GSBPL
    Statens Serum Institute
    Biomed Lublin
    ANLIS Malbran
    Funda????o Ataulpho de Paiva
    BB-NCIPD
    Taj Pharmaceuticals
    Bio Farma
    Microgen
    Torlakinstitut
    Institut Pasteur de Tunis
    IVAC

Market segment by region, regional analysis covers

    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe BCG Vaccine for Tuberculosis (TB) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of BCG Vaccine for Tuberculosis (TB), with price, sales, revenue and global market share of BCG Vaccine for Tuberculosis (TB) from 2019 to 2022.
Chapter 3, the BCG Vaccine for Tuberculosis (TB) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the BCG Vaccine for Tuberculosis (TB) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and BCG Vaccine for Tuberculosis (TB) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of BCG Vaccine for Tuberculosis (TB).
Chapter 13, 14, and 15, to describe BCG Vaccine for Tuberculosis (TB) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 BCG Vaccine for Tuberculosis (TB) Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Immune Type
        1.2.3 Therapy Type
    1.3 Market Analysis by Application
        1.3.1 Overview: Global BCG Vaccine for Tuberculosis (TB) Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global BCG Vaccine for Tuberculosis (TB) Market Size & Forecast
        1.4.1 Global BCG Vaccine for Tuberculosis (TB) Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global BCG Vaccine for Tuberculosis (TB) Sales in Volume (2017-2028)
        1.4.3 Global BCG Vaccine for Tuberculosis (TB) Price (2017-2028) 
    1.5 Global BCG Vaccine for Tuberculosis (TB) Production Capacity Analysis
        1.5.1 Global BCG Vaccine for Tuberculosis (TB) Total Production Capacity (2017-2028)
        1.5.2 Global BCG Vaccine for Tuberculosis (TB) Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 BCG Vaccine for Tuberculosis (TB) Market Drivers
        1.6.2 BCG Vaccine for Tuberculosis (TB) Market Restraints
        1.6.3 BCG Vaccine for Tuberculosis (TB) Trends Analysis
2 Manufacturers Profiles
    2.1 Merck
        2.1.1 Merck Details
        2.1.2 Merck Major Business
        2.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product and Services
        2.1.4 Merck BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Sanofi Pasteur
        2.2.1 Sanofi Pasteur Details
        2.2.2 Sanofi Pasteur Major Business
        2.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product and Services
        2.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Japan BCG Lab
        2.3.1 Japan BCG Lab Details
        2.3.2 Japan BCG Lab Major Business
        2.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product and Services
        2.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 China National Biotec
        2.4.1 China National Biotec Details
        2.4.2 China National Biotec Major Business
        2.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product and Services
        2.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 AJ Vaccines
        2.5.1 AJ Vaccines Details
        2.5.2 AJ Vaccines Major Business
        2.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product and Services
        2.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Serum Institute of India
        2.6.1 Serum Institute of India Details
        2.6.2 Serum Institute of India Major Business
        2.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product and Services
        2.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Intervax
        2.7.1 Intervax Details
        2.7.2 Intervax Major Business
        2.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product and Services
        2.7.4 Intervax BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 GSBPL
        2.8.1 GSBPL Details
        2.8.2 GSBPL Major Business
        2.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product and Services
        2.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Statens Serum Institute
        2.9.1 Statens Serum Institute Details
        2.9.2 Statens Serum Institute Major Business
        2.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product and Services
        2.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Biomed Lublin
        2.10.1 Biomed Lublin Details
        2.10.2 Biomed Lublin Major Business
        2.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product and Services
        2.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 ANLIS Malbran
        2.11.1 ANLIS Malbran Details
        2.11.2 ANLIS Malbran Major Business
        2.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product and Services
        2.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Funda????o Ataulpho de Paiva
        2.12.1 Funda????o Ataulpho de Paiva Details
        2.12.2 Funda????o Ataulpho de Paiva Major Business
        2.12.3 Funda????o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services
        2.12.4 Funda????o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 BB-NCIPD
        2.13.1 BB-NCIPD Details
        2.13.2 BB-NCIPD Major Business
        2.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product and Services
        2.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Taj Pharmaceuticals
        2.14.1 Taj Pharmaceuticals Details
        2.14.2 Taj Pharmaceuticals Major Business
        2.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product and Services
        2.14.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Bio Farma
        2.15.1 Bio Farma Details
        2.15.2 Bio Farma Major Business
        2.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product and Services
        2.15.4 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Microgen
        2.16.1 Microgen Details
        2.16.2 Microgen Major Business
        2.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product and Services
        2.16.4 Microgen BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Torlakinstitut
        2.17.1 Torlakinstitut Details
        2.17.2 Torlakinstitut Major Business
        2.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product and Services
        2.17.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.18 Institut Pasteur de Tunis
        2.18.1 Institut Pasteur de Tunis Details
        2.18.2 Institut Pasteur de Tunis Major Business
        2.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product and Services
        2.18.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.19 IVAC
        2.19.1 IVAC Details
        2.19.2 IVAC Major Business
        2.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product and Services
        2.19.4 IVAC BCG Vaccine for Tuberculosis (TB) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 BCG Vaccine for Tuberculosis (TB) Breakdown Data by Manufacturer
    3.1 Global BCG Vaccine for Tuberculosis (TB) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in BCG Vaccine for Tuberculosis (TB)
    3.4 Market Concentration Rate
        3.4.1 Top 3 BCG Vaccine for Tuberculosis (TB) Manufacturer Market Share in 2021
        3.4.2 Top 6 BCG Vaccine for Tuberculosis (TB) Manufacturer Market Share in 2021
    3.5 Global BCG Vaccine for Tuberculosis (TB) Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and BCG Vaccine for Tuberculosis (TB) Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global BCG Vaccine for Tuberculosis (TB) Market Size by Region
        4.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales in Volume by Region (2017-2028)
        4.1.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2028)
    4.2 North America BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028)
    4.3 Europe BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028)
    4.4 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028)
    4.5 South America BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028)
    4.6 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global BCG Vaccine for Tuberculosis (TB) Sales in Volume by Type (2017-2028)
    5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2017-2028)
    5.3 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global BCG Vaccine for Tuberculosis (TB) Sales in Volume by Application (2017-2028)
    6.2 Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2017-2028)
    6.3 Global BCG Vaccine for Tuberculosis (TB) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2028)
    7.2 North America BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2028)
    7.3 North America BCG Vaccine for Tuberculosis (TB) Market Size by Country
        7.3.1 North America BCG Vaccine for Tuberculosis (TB) Sales in Volume by Country (2017-2028)
        7.3.2 North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2028)
    8.2 Europe BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2028)
    8.3 Europe BCG Vaccine for Tuberculosis (TB) Market Size by Country
        8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales in Volume by Country (2017-2028)
        8.3.2 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2028)
    9.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2028)
    9.3 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Market Size by Region
        9.3.1 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2028)
    10.2 South America BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2028)
    10.3 South America BCG Vaccine for Tuberculosis (TB) Market Size by Country
        10.3.1 South America BCG Vaccine for Tuberculosis (TB) Sales in Volume by Country (2017-2028)
        10.3.2 South America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2028)
    11.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2028)
    11.3 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Market Size by Country
        11.3.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of BCG Vaccine for Tuberculosis (TB) and Key Manufacturers
    12.2 Manufacturing Costs Percentage of BCG Vaccine for Tuberculosis (TB)
    12.3 BCG Vaccine for Tuberculosis (TB) Production Process
    12.4 BCG Vaccine for Tuberculosis (TB) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 BCG Vaccine for Tuberculosis (TB) Typical Distributors
    13.3 BCG Vaccine for Tuberculosis (TB) Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

List of Tables Table 1. Global BCG Vaccine for Tuberculosis (TB) Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 2. Global BCG Vaccine for Tuberculosis (TB) Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 3. Merck Basic Information, Manufacturing Base and Competitors Table 4. Merck Major Business Table 5. Merck BCG Vaccine for Tuberculosis (TB) Product and Services Table 6. Merck BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors Table 8. Sanofi Pasteur Major Business Table 9. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product and Services Table 10. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 11. Japan BCG Lab Basic Information, Manufacturing Base and Competitors Table 12. Japan BCG Lab Major Business Table 13. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product and Services Table 14. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 15. China National Biotec Basic Information, Manufacturing Base and Competitors Table 16. China National Biotec Major Business Table 17. China National Biotec BCG Vaccine for Tuberculosis (TB) Product and Services Table 18. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 19. AJ Vaccines Basic Information, Manufacturing Base and Competitors Table 20. AJ Vaccines Major Business Table 21. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product and Services Table 22. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors Table 24. Serum Institute of India Major Business Table 25. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product and Services Table 26. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 27. Intervax Basic Information, Manufacturing Base and Competitors Table 28. Intervax Major Business Table 29. Intervax BCG Vaccine for Tuberculosis (TB) Product and Services Table 30. Intervax BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 31. GSBPL Basic Information, Manufacturing Base and Competitors Table 32. GSBPL Major Business Table 33. GSBPL BCG Vaccine for Tuberculosis (TB) Product and Services Table 34. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 35. Statens Serum Institute Basic Information, Manufacturing Base and Competitors Table 36. Statens Serum Institute Major Business Table 37. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product and Services Table 38. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 39. Biomed Lublin Basic Information, Manufacturing Base and Competitors Table 40. Biomed Lublin Major Business Table 41. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product and Services Table 42. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 43. ANLIS Malbran Basic Information, Manufacturing Base and Competitors Table 44. ANLIS Malbran Major Business Table 45. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product and Services Table 46. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 47. Funda????o Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors Table 48. Funda????o Ataulpho de Paiva Major Business Table 49. Funda????o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product and Services Table 50. Funda????o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 51. BB-NCIPD Basic Information, Manufacturing Base and Competitors Table 52. BB-NCIPD Major Business Table 53. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product and Services Table 54. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 55. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 56. Taj Pharmaceuticals Major Business Table 57. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product and Services Table 58. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 59. Bio Farma Basic Information, Manufacturing Base and Competitors Table 60. Bio Farma Major Business Table 61. Bio Farma BCG Vaccine for Tuberculosis (TB) Product and Services Table 62. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 63. Microgen Basic Information, Manufacturing Base and Competitors Table 64. Microgen Major Business Table 65. Microgen BCG Vaccine for Tuberculosis (TB) Product and Services Table 66. Microgen BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 67. Torlakinstitut Basic Information, Manufacturing Base and Competitors Table 68. Torlakinstitut Major Business Table 69. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product and Services Table 70. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 71. Institut Pasteur de Tunis Basic Information, Manufacturing Base and Competitors Table 72. Institut Pasteur de Tunis Major Business Table 73. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product and Services Table 74. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 75. IVAC Basic Information, Manufacturing Base and Competitors Table 76. IVAC Major Business Table 77. IVAC BCG Vaccine for Tuberculosis (TB) Product and Services Table 78. IVAC BCG Vaccine for Tuberculosis (TB) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 79. Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units) Table 80. Global BCG Vaccine for Tuberculosis (TB) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million) Table 81. Market Position of Manufacturers in BCG Vaccine for Tuberculosis (TB), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021 Table 82. Global BCG Vaccine for Tuberculosis (TB) Production Capacity by Company, (K Units): 2020 VS 2021 Table 83. Head Office and BCG Vaccine for Tuberculosis (TB) Production Site of Key Manufacturer Table 84. BCG Vaccine for Tuberculosis (TB) New Entrant and Capacity Expansion Plans Table 85. BCG Vaccine for Tuberculosis (TB) Mergers & Acquisitions in the Past Five Years Table 86. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022) & (K Units) Table 87. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2023-2028) & (K Units) Table 88. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022) & (USD Million) Table 89. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2023-2028) & (USD Million) Table 90. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 91. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 92. Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2017-2022) & (USD Million) Table 93. Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2023-2028) & (USD Million) Table 94. Global BCG Vaccine for Tuberculosis (TB) Price by Type (2017-2022) & (US$/Unit) Table 95. Global BCG Vaccine for Tuberculosis (TB) Price by Type (2023-2028) & (US$/Unit) Table 96. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 97. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 98. Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2017-2022) & (USD Million) Table 99. Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2023-2028) & (USD Million) Table 100. Global BCG Vaccine for Tuberculosis (TB) Price by Application (2017-2022) & (US$/Unit) Table 101. Global BCG Vaccine for Tuberculosis (TB) Price by Application (2023-2028) & (US$/Unit) Table 102. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units) Table 103. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2023-2028) & (K Units) Table 104. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (USD Million) Table 105. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2023-2028) & (USD Million) Table 106. North America BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 107. North America BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 108. North America BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 109. North America BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 110. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units) Table 111. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2023-2028) & (K Units) Table 112. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (USD Million) Table 113. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2023-2028) & (USD Million) Table 114. Europe BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 115. Europe BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 116. Europe BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 117. Europe BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 118. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022) & (K Units) Table 119. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2023-2028) & (K Units) Table 120. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022) & (USD Million) Table 121. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2023-2028) & (USD Million) Table 122. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 123. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 124. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 125. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 126. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units) Table 127. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2023-2028) & (K Units) Table 128. South America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (USD Million) Table 129. South America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2023-2028) & (USD Million) Table 130. South America BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 131. South America BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 132. South America BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 133. South America BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 134. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022) & (K Units) Table 135. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2023-2028) & (K Units) Table 136. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022) & (USD Million) Table 137. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue by Region (2023-2028) & (USD Million) Table 138. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units) Table 139. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Type (2023-2028) & (K Units) Table 140. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Application (2017-2022) & (K Units) Table 141. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Application (2023-2028) & (K Units) Table 142. BCG Vaccine for Tuberculosis (TB) Raw Material Table 143. Key Manufacturers of BCG Vaccine for Tuberculosis (TB) Raw Materials Table 144. Direct Channel Pros & Cons Table 145. Indirect Channel Pros & Cons Table 146. BCG Vaccine for Tuberculosis (TB) Typical Distributors Table 147. BCG Vaccine for Tuberculosis (TB) Typical Customers List of Figures Figure 1. BCG Vaccine for Tuberculosis (TB) Picture Figure 2. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type in 2021 Figure 3. Immune Type Figure 4. Therapy Type Figure 5. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application in 2021 Figure 6. Hospitals Figure 7. Clinics Figure 8. Others Figure 9. Global BCG Vaccine for Tuberculosis (TB) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028 Figure 10. Global BCG Vaccine for Tuberculosis (TB) Revenue and Forecast (2017-2028) & (USD Million) Figure 11. Global BCG Vaccine for Tuberculosis (TB) Sales (2017-2028) & (K Units) Figure 12. Global BCG Vaccine for Tuberculosis (TB) Price (2017-2028) & (US$/Unit) Figure 13. Global BCG Vaccine for Tuberculosis (TB) Production Capacity (2017-2028) & (K Units) Figure 14. Global BCG Vaccine for Tuberculosis (TB) Production Capacity by Geographic Region: 2022 VS 2028 Figure 15. BCG Vaccine for Tuberculosis (TB) Market Drivers Figure 16. BCG Vaccine for Tuberculosis (TB) Market Restraints Figure 17. BCG Vaccine for Tuberculosis (TB) Market Trends Figure 18. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturer in 2021 Figure 19. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturer in 2021 Figure 20. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021 Figure 21. Top 3 BCG Vaccine for Tuberculosis (TB) Manufacturer (Revenue) Market Share in 2021 Figure 22. Top 6 BCG Vaccine for Tuberculosis (TB) Manufacturer (Revenue) Market Share in 2021 Figure 23. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2028) Figure 24. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2028) Figure 25. North America BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028) & (USD Million) Figure 26. Europe BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028) & (USD Million) Figure 27. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028) & (USD Million) Figure 28. South America BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028) & (USD Million) Figure 29. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue (2017-2028) & (USD Million) Figure 30. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2028) Figure 31. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2017-2028) Figure 32. Global BCG Vaccine for Tuberculosis (TB) Price by Type (2017-2028) & (US$/Unit) Figure 33. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 34. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2017-2028) Figure 35. Global BCG Vaccine for Tuberculosis (TB) Price by Application (2017-2028) & (US$/Unit) Figure 36. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2028) Figure 37. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 38. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2028) Figure 39. North America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2028) Figure 40. United States BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 41. Canada BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 42. Mexico BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 43. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2028) Figure 44. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 45. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2028) Figure 46. Europe BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2028) Figure 47. Germany BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 48. France BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 49. United Kingdom BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 50. Russia BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 51. Italy BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 52. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2028) Figure 53. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 54. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2028) Figure 55. Asia-Pacific BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2028) Figure 56. China BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 57. Japan BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 58. Korea BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 59. India BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. Southeast Asia BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. Australia BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2028) Figure 63. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 64. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2028) Figure 65. South America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2028) Figure 66. Brazil BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 67. Argentina BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2028) Figure 69. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2028) Figure 70. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2028) Figure 71. Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2028) Figure 72. Turkey BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. Egypt BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 74. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 75. South Africa BCG Vaccine for Tuberculosis (TB) Revenue and Growth Rate (2017-2028) & (USD Million) Figure 76. Manufacturing Cost Structure Analysis of BCG Vaccine for Tuberculosis (TB) in 2021 Figure 77. Manufacturing Process Analysis of BCG Vaccine for Tuberculosis (TB) Figure 78. BCG Vaccine for Tuberculosis (TB) Industrial Chain Figure 79. Sales Channel: Direct Channel vs Indirect Channel Figure 80. Methodology Figure 81. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us